152 related articles for article (PubMed ID: 21244216)
1. Nanobody; an old concept and new vehicle for immunotargeting.
Rahbarizadeh F; Ahmadvand D; Sharifzadeh Z
Immunol Invest; 2011; 40(3):299-338. PubMed ID: 21244216
[TBL] [Abstract][Full Text] [Related]
2. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
5. [Advances in the study of natural small molecular antibody].
Zhu L; Zhang DP
Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
[TBL] [Abstract][Full Text] [Related]
6. The first antibody therapy for cancer: a personal experience.
Grillo-López AJ
Expert Rev Anticancer Ther; 2013 Apr; 13(4):399-406. PubMed ID: 23560835
[TBL] [Abstract][Full Text] [Related]
7. [The future of antibody fragments, made of a single immunoglobulin domain].
Chames P; Baty D
Med Sci (Paris); 2009 Dec; 25(12):1159-62. PubMed ID: 20035698
[TBL] [Abstract][Full Text] [Related]
8. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
[TBL] [Abstract][Full Text] [Related]
9. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for cancer: construction, expression and functional characterization of chimeric antibodies.
Motmans K; Thirion S; Heyligen H; Janssens J; Raus J; Vandevyver C
Eur J Cancer Prev; 1996 Dec; 5(6):512-9. PubMed ID: 9061286
[TBL] [Abstract][Full Text] [Related]
11. Antibody guided precision radiation therapy.
Brady ED; Milenic DE; Brechbiel MW
Discov Med; 2004 Jun; 4(22):213-9. PubMed ID: 20704989
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
[TBL] [Abstract][Full Text] [Related]
13. A novel single-chain variable fragment antibody against FGF-1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF-1.
Shi HL; Yang T; Deffar K; Dong CG; Liu JY; Fu CL; Zheng DX; Qin B; Wang JJ; Wang XZ; Zhu XJ
IUBMB Life; 2011 Feb; 63(2):129-37. PubMed ID: 21360642
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
Cazin JL; Gosselin P; Demaille A
Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
[TBL] [Abstract][Full Text] [Related]
15. Possible applications of antibodies or their genes in cancer therapy.
Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
[TBL] [Abstract][Full Text] [Related]
16. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.
Skrlj N; Serbec VC; Dolinar M
Appl Biochem Biotechnol; 2010 Mar; 160(6):1808-21. PubMed ID: 19597999
[TBL] [Abstract][Full Text] [Related]
17. [Application of nanobody in cancer treatment].
Wu Y; Hao X; Li M
Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1085-1090. PubMed ID: 28869728
[TBL] [Abstract][Full Text] [Related]
18. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
Vollmers HP; Brändlein S
Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
